CENTURY(SZ:300078) 梧桐树下V·2025-07-13 05:25Core Viewpoint - The article discusses the disciplinary actions taken by the Shenzhen Stock Exchange against Tianjian Accounting Firm and its certified public accountants for their involvement in the financial fraud case of Sichuang Medical Technology Co., Ltd, highlighting the serious implications of falsified financial statements and inadequate auditing practices [1][4]. Group 1: Disciplinary Actions - Tianjian Accounting Firm and its certified public accountants Hu Yanlong, Xu Lili, and Ni Bin received disciplinary actions for their roles in the financial fraud case involving Sichuang Medical [1][4]. - Hu Yanlong and Xu Lili are prohibited from signing any issuance and disclosure documents from June 28, 2025, to June 27, 2026 [1][4]. - Tianjian Accounting Firm received a public reprimand, while Hu Yanlong and Xu Lili also faced public reprimands, and Ni Bin received a notice of criticism [1][4]. Group 2: Fraudulent Activities - Sichuang Medical was found to have fabricated significant false content in its public offering documents, including financial data from 2017 to 2020 [1][7]. - The company inflated revenue and profits through fictitious transactions with subsidiaries and early revenue recognition practices [1][7]. - The 2019 and 2020 annual reports of Sichuang Medical contained false records, failing to accurately disclose financial data [1][7]. Group 3: Audit Failures - Tianjian Accounting Firm failed to effectively identify and assess fraud risks during the audit of Sichuang Medical [1][8]. - The firm did not implement adequate audit procedures regarding abnormal revenue recognition and did not obtain sufficient appropriate audit evidence [1][9][10]. - There were discrepancies between the audit documentation and actual execution, indicating a lack of due diligence in the auditing process [1][12][13].